<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <id>https://recalls.watch/feed/substance-albuterol.xml</id>
  <title>Recalls Watch: Albuterol</title>
  <link rel="self" href="https://recalls.watch/feed/substance-albuterol.xml"/>
  <link href="https://recalls.watch/alerts/"/>
  <updated>2026-04-22T00:00:00Z</updated>
  <entry>
    <id>https://recalls.watch/recall/fda/98596/</id>
    <title>Nephron SC, LLC: Albuterol Sulfate Inhalation Solution</title>
    <link href="https://recalls.watch/recall/fda/98596/"/>
    <updated>2026-04-22T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Labelling: Illegible label</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/97304/</id>
    <title>Cipla USA, Inc.: Albuterol Sulfate</title>
    <link href="https://recalls.watch/recall/fda/97304/"/>
    <updated>2025-08-27T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Failed Stability Specifications: Out of specification results was observed in Induction Port during the analysis of Particle size distribution at the 12-month time point.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/94289/</id>
    <title>Cipla USA, Inc.: Ipratropium Bromide and Albuterol Sulfate Inhalation Solution USP</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=94289"/>
    <updated>2024-05-01T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Short fill: Complaints received of less fill volume in respule and few drops of liquid observed in the intact pouch.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/89450/</id>
    <title>CARDINAL HEALTHCARE: Ipratropium Bromide and Albuterol Sulfate Inhalation Solution and 41 more</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=89450"/>
    <updated>2024-01-03T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/n-cipla-issues-voluntary-nationwide-recall-six-batches-albuterol-sulfate-inhalatio/</id>
    <title>Cipla: Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation)</title>
    <link href="https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/cipla-issues-voluntary-nationwide-recall-six-batches-albuterol-sulfate-inhalation-aerosol-90-mcg-200"/>
    <updated>2023-07-07T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Failure to deliver the recommended dose</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/91788/</id>
    <title>Akorn, Inc.: Atropine Sulfate Ophthalmic Solution and 85 more</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=91788"/>
    <updated>2023-06-07T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: CGMP Deviations: Firm went out of business and could no longer continue stability studies.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/77329/</id>
    <title>GlaxoSmithKline, LLC: Ventolin HFA</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=77329"/>
    <updated>2017-05-31T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Defective Delivery System: Elevated number of units with out of specification results for leak rate</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/76839/</id>
    <title>GlaxoSmithKline, LLC: Ventolin HFA</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=76839"/>
    <updated>2017-04-12T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Defective Delivery System: Elevated number of units with out of specification results for leak rate.</summary>
  </entry>
</feed>
